Compounds and compositions for treating solid tumors by intratumoral administration
US11752162B2 · kind B2 · utility
0Cited by
5References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 2018 |
| Grant date | Sep 12, 2023 |
| Priority date | — |
| Expiry date | Jun 20, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provided herein includes pharmaceutical compositions comprising a TLR7 agonist having the structure of Formula (A), aluminum-containing particles, and one or more pharmaceutically acceptable excipient. The invention further provides the use of such compositions in the treatment of solid tumors either alone or in combination with one or more additional pharmaceutical compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.